4//SEC Filing
Versartis, Inc. 4
Accession 0001209191-17-025821
CIK 0001513818operating
Filed
Apr 4, 8:00 PM ET
Accepted
Apr 5, 7:02 PM ET
Size
9.0 KB
Accession
0001209191-17-025821
Insider Transaction Report
Form 4
Versartis, Inc.VSAR
Hislop Colin
Chief Medical Officer
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2017-04-04−35,000→ 188,100 totalExercise: $8.17Exp: 2026-04-03→ Common Stock (35,000 underlying) - Exercise/Conversion
Common Stock
2017-04-04$8.17/sh+35,000$285,950→ 59,500 total - Sale
Common Stock
2017-04-04$21.20/sh−35,000$742,000→ 24,500 total
Footnotes (3)
- [F1]Shares sold pursuant to a 10b5-1 plan.
- [F2]The shares were sold at prices ranging from $20.90 to $21.65. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F3]1/4th of the total number of shares subject to the option shall vest on the first yearly anniversary of the vesting commencement date and 1/36th of the remaining number of shares subject to the option shall vest on each monthly anniversary of the vesting commencement date thereafter.
Documents
Issuer
Versartis, Inc.
CIK 0001513818
Entity typeoperating
IncorporatedTX
Related Parties
1- filerCIK 0001513818
Filing Metadata
- Form type
- 4
- Filed
- Apr 4, 8:00 PM ET
- Accepted
- Apr 5, 7:02 PM ET
- Size
- 9.0 KB